Braidwell »

Caredx shares owned by Braidwell

Quarter-by-quarter ownership of Caredx (CDNA) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Caredx

Tip: Access up to 7 years of quarterly data

All positions including Caredx held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caredx by Braidwell

Quarter filed Position value Share count Share price at filing
2025-09-30 $32M 2.2M 14.54

More positions owned by Braidwell

Guardant Health Debt 1.250% 2/1 (Principal)
Caris Life Sciences (CAI)
Novocure Note 11/0 (Principal)
Xenon Pharmaceuticals (XENE)
Cg Oncology (CGON)
Neurocrine Biosciences (NBIX)
Repligen Corp Note 1.000%12/1 (Principal)
Krystal Biotech (KRYS)
Nuvalent Inc-a (NUVL)
Neogenomics Note 0.250% 1/1 (Principal)
Soleno Therapeutics (SLNO)
Irhythm Technologies Note 1.500% 9/0 (Principal)
Edgewise Therapeutics (EWTX)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Inspire Med Sys (INSP)

View all positions for Braidwell

Top funds holding Caredx

BlackRock
Vanguard Group
Bamco
State Street Corporation
Ophir Asset Management Pty
Deerfield Management Company
Braidwell
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Gagnon Securities
Geode Capital Management
Dimensional Fund Advisors
Renaissance Technologies
Connor, Clark & Lunn Investment Management

View all funds holding Caredx